Actively Recruiting
Metabolic Biomarkers in Thoracic Cancers
Led by University of Texas Southwestern Medical Center · Updated on 2026-05-01
200
Participants Needed
1
Research Sites
771 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this research study is to develop a method of using magnetic resonance imaging (MRI) to evaluate lung tumors and other thoracic malignancies. An MRI is a scanning device that uses magnets to make images (pictures) of the body. This study is being done to determine what series of reactions (metabolic pathways) pulmonary nodules use as they burn sugar as fuel for growth. The manner in which the tumor burns (metabolizes) sugar for fuel is being investigated by using a natural, slightly modified, sugar solution (13C-glucose) and studying a small sample of the tumor once it is removed at the time of surgery.
CONDITIONS
Official Title
Metabolic Biomarkers in Thoracic Cancers
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients must have known or probable malignant lesions requiring surgical biopsy or excision.
- Subjects of all races and ethnic origins over 18 years of age.
You will not qualify if you...
- Not a surgical candidate.
- Poorly controlled diabetes.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Texas Southwestern Medical Center
Dallas, Texas, United States, 75390
Actively Recruiting
Research Team
E
Ebele Mbanugo, Ed.D, CCRP
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
BASIC_SCIENCE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here